An innovative approach to the treatment of Gaucher disease and possibly other metabolic disorders of the brain.

Abstract excerpt

The extraordinary benefit of enzyme replacement therapy (ERT) on the systemic manifestations of Gaucher disease was demonstrated in 1991. Since that time, investigators have devoted substantial effort to improve the delivery of enzymes to the brain because many hereditary metabolic disorders are characterized by extensive central nervous system involvement. Because the required supplemental enzyme is too large to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Blood-Brain Barrier
• Share to Brain Diseases, Metabolic